Bgat Hypoglycemia

1. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005; 28:1245-1249.

2. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46:271-286.

3. Deary IJ. Symptoms of hypoglycaemia and effects on mental performance and emotions. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:25-48.

4. Sommerfield AJ, Deary IJ, Frier BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with Type 2 diabetes. Diabetes Care 2004; 27:2335-2340.

5. Cryer PE. Glucose counterregulation in man. Diabetes 1981; 30:261-264.

6. Wright R, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diab/Metab Res Revs 2008; 24:353-63.

7. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med 2001; 18: 690-705.

8. Tallroth G, Lindgren M, Stenberg G, Rosen I, Agardh CD. Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetologia 1990; 33:319-323.

9. Lindgren M, Eckert B, Stenberg G, Agardh CD. Restitution of neurophysiological functions, performance, and subjective symptoms after moderate insulin-induced hypoglycaemia in non-diabetic men. Diabet Med 1996; 13:218-225.

10. Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia 1992; 35:958-961.

11. Frier BM. Impaired awareness of hypoglycaemia. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:141-170.

12. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991; 8:217-222.

13. Pedersen-Bjergaard U, Pramming S, Heller SR, et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20:479-486.

14. The Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.

15. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37:278-285.

16. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993; 10:238-245.

17. ter Braak EWMT, Appelman AMMF, Van de Laak MF, Stolk RP, Van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000; 23:1467-1471.

18. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and type 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50:1140-1147.

19. The Diabetes Control and Complications Trial Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 1987; 10:1-19.

20. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28:2948-2961.

21. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VACSDM): results of the feasibility trial. Diabetes Care 1995; 18:1113-1123.

22. Leese GP, Wang J, Broomhall J, et al. (for the DARTS/MEMO Collaboration). Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003; 26:1176-1180.

23. Donnelly LA, Morris AD, Frier BM, et al. (for the DARTS/MEMO Collaboration). Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005; 22:449-455.

24. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003; 20:1016-1021.

25. Hepburn DA, MacLeod KM, Pell ACH, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with Type 2 diabetes treated with insulin. Diabet Med 1993; 10:231-237.

26. Allen KV, Frier BM. Nocturnal hypoglycaemia: clinical manifestations and therapeutic strategies toward prevention. Endocrine Practice 2003; 9:530-543.

27. Heller SR. Nocturnal hypoglycaemia. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier, B.M., Fisher, M, eds. Chichester: John Wiley & Sons; 2007:83-99.

28. Thorsteinsson B, Pramming S, Lauritzen T, Binder C. Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations. Diabet Med 1986; 3:147-151.

29. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90:450-459.

30. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338:1657-1662.

31. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 2003; 46:89-96.

32. Zammitt NN, Geddes J, Warren RE, Marioni R, Ashby JP, Frier BM. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist? Diabet Med 2007; 24:449-454.

33. Dewan S, Gfflett A, Mugarza JA, Dovey TM, Halford JCG, Wilding JPH. Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent test meal. Diab Metab Res Revs 2004; 20:405-410.

34. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. J Am Med Assoc 1984; 252:3378-381.

35. Slama G, Traynard PY, Desplanque N, et al. The search for an optimised treatment of hypo-glycemia. Carbohydrates in tablets, solution, or gel for the correction of insulin reactions. Arch Intern Med 1990; 150:589-593.

36. MacCuish AC. Treatment of hypoglycaemia. In: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. Frier BM, Fisher BM, eds. London: Edward Arnold, 1993:212-221.

37. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2008; 360:129-139.

38. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med 2008; 358:2545-2559.

39. Fisher M, Heller S. Mortality, cardiovascular morbidity and possible effects of hypoglycaemia on diabetic complications. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:265-283.

40. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991; 8:49-58.

41. MacLeod KM, Hepburn DA, Deary IJ, Goodwin GM, Dougall N, Ebmeier KP, Frier BM. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 1994; 37:257-263.

42. Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons, 2007:49-81.

43. Bjorgaas M, Sand T, Vik T, Jorde R. Quantitative EEG during controlled hypoglycaemia in diabetic and non-diabetic children. Diabet Med 1998; 15:30-37.

44. Bottcher J, Kunze A, Kurrat C, et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 2005; 36:e20-e22.

45. Cordonnier C, Oppenheim C, Lamy C, Meder JF, Mas JL. Serial diffusion and perfusion-weighted MR in transient hypoglycemia. Neurology 2005; 65:175.

46. Strachan MWJ, Abraha HD, Sherwood RA, Lammie GA, Deary IJ, Ewing FME, Perros, P, Frier BM. Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus. Diab/Metab Res Revs 1999; 15:5-12.

47. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16:466-471.

48. Cryer PE. Hypoglycaemia: the limiting factor in the management of Type 1 and Type 2 diabetes. Diabetologia 2002; 45:937-948.

49. Gerich JE, Bolli GB. Counterregulatory failure. In: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. Frier BM, Fisher BM, eds. London: Edward Arnold; 1993:253-267.

50. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. New Engl J Med 1983;308:485-491.

51. Bolli GB, Tsalikian E, Haymond MW, Cryer PE, Gerich JE. Defective glucose counterreg-ulation after subcutaneous insulin in non-insulin-dependent diabetes mellitus. J Clin Invest 1984;73:1532-1541.

52. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J 1990; 301:783-787.

53. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypogly-caemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 1990; 7:711-717.

54. Cox D.J, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2). Long term benefits. Diabetes Care 2001; 24:637-642.

55 Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness ofhypo-glycaemia in adults with Type 1 diabetes. Diabet Med 2008; 25:501-504.

56. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with impaired awareness of hypoglycemia. Diabetes Care 1994; 17:697-703.

57. Segel SA, Paramore DA, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51:724-733.

58. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004; 350:2272-2279.

59. Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Education and Counseling 2007; 68:10-15.

60. Frier BM. Living with hypoglycaemia. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:309-332.

61. Frier BM. How hypoglycaemia can affect the Life of a person with diabetes. Diab Metab Res Revs 2008; 24:87-92.

62. Cox DJ, Gonder-Frederick LA, Kovatchev B, Julian DM, Clarke WL. Progressive hypo-glycemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000; 23:163-170.

63. Graveling AJ, Warren RE, Frier BM. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. Diabet Med 2004; 21:1014-1019.

64. Siebenhofer A, Plank J, Berghold A, et al. Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia 2004; 47:1895-1905.

65. Pickup JC, Sutton A.J. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25:765-774.

66. Klonoff DC. Continuous glucose monitoring. Roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28:1231-1239.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment